These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17210711)

  • 21. A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells.
    Sauer MG; Ericson ME; Weigel BJ; Herron MJ; Panoskaltsis-Mortari A; Kren BT; Levine BL; Serody JS; June CH; Taylor PA; Blazar BR
    Cancer Res; 2004 Jun; 64(11):3914-21. PubMed ID: 15173002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells.
    Flanagan K; Moroziewicz D; Kwak H; Hörig H; Kaufman HL
    Cell Immunol; 2004; 231(1-2):75-84. PubMed ID: 15919372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection.
    Petersen CC; Petersen MS; Agger R; Hokland ME
    J Immunother; 2006; 29(3):241-9. PubMed ID: 16699367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
    Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
    Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion.
    Sussman JJ; Parihar R; Winstead K; Finkelman FD
    Cancer Res; 2004 Dec; 64(24):9124-30. PubMed ID: 15604282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
    Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
    Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.
    Chen A; Liu S; Park D; Kang Y; Zheng G
    Cancer Res; 2007 Feb; 67(3):1291-8. PubMed ID: 17283166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity.
    Park MY; Kim CH; Sohn HJ; Oh ST; Kim SG; Kim TG
    Vaccine; 2007 Oct; 25(42):7322-30. PubMed ID: 17889413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel approach to generate host antitumor T cells: adoptive immunotherapy by T cells maturing in xenogeneic thymus.
    Zhao Y; Sun Y; Niu Z; Li Q; Peng J; Wang J; Langnas AN
    J Immunother; 2007 Jan; 30(1):83-8. PubMed ID: 17198086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE; Carrio R; Malek TR
    Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
    Mueller K; Schweier O; Pircher H
    Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
    Hu K; Xiong J; Ji K; Sun H; Wang J; Liu H
    Immunol Lett; 2007 Oct; 113(1):19-28. PubMed ID: 17868906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Li B; Lin J; Vanroey M; Jure-Kunkel M; Jooss K
    Clin Immunol; 2007 Oct; 125(1):76-87. PubMed ID: 17706463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes.
    Rossi GR; Mautino MR; Unfer RC; Seregina TM; Vahanian N; Link CJ
    Cancer Res; 2005 Nov; 65(22):10555-61. PubMed ID: 16288048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
    Damås JK; Smith C; Øie E; Fevang B; Halvorsen B; Waehre T; Boullier A; Breland U; Yndestad A; Ovchinnikova O; Robertson AK; Sandberg WJ; Kjekshus J; Taskén K; Frøland SS; Gullestad L; Hansson GK; Quehenberger O; Aukrust P
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):614-20. PubMed ID: 17170367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-dependent overexpression of CCL21 is an underlying cause of progressive lymphoaccumulation in generalized lymphoproliferative disorder.
    Wiede F; Vana K; Sedger LM; Lechner A; Körner H
    Eur J Immunol; 2007 Feb; 37(2):351-7. PubMed ID: 17236235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.